GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gubra AS (OCSE:GUBRA) » Definitions » Loans Receivable

Gubra AS (OCSE:GUBRA) Loans Receivable : kr0.0 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Gubra AS Loans Receivable?

Gubra AS's Loans Receivable for the quarter that ended in Dec. 2023 was kr0.0 Mil.


Gubra AS Loans Receivable Historical Data

The historical data trend for Gubra AS's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gubra AS Loans Receivable Chart

Gubra AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Loans Receivable
- - - - -

Gubra AS Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Loans Receivable Get a 7-Day Free Trial - - - - -

Gubra AS Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Gubra AS Loans Receivable Related Terms

Thank you for viewing the detailed overview of Gubra AS's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Gubra AS (OCSE:GUBRA) Business Description

Traded in Other Exchanges
Address
Hørsholm Kongevej 11B, Hørsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases.

Gubra AS (OCSE:GUBRA) Headlines

No Headlines